Peptable

Comparison

KPV vs PT-141

Also see:

KPVPT-141

Function

While KPV is investigated as an anti-inflammatory and barrier-protective agent in skin and mucosal models, reducing pro-inflammatory cytokines and promoting tissue repair684, PT-141 is FDA-approved for treatment of hypoactive sexual desire disorder in premenopausal women and is studied for sexual dysfunction in other populations, increasing sexual desire via CNS melanocortin pathways42101.

Mechanism

While KPV works as the C-terminal Lys-Pro-Val tripeptide fragment of α-MSH, which exerts potent anti-inflammatory effects largely via inhibition of NF-κB signaling and modulation of cytokine expression, with many actions independent of classical melanocortin receptor activation684, PT-141 is the synthetic melanocortin receptor agonist bremelanotide, an analog of α-MSH that activates central MC3R and MC4R to modulate neuronal circuits governing sexual desire and arousal3242101.

Receptor

KPV

No single primary receptor; the KPV motif can influence melanocortin receptor binding profiles (MC1R–MC5R), but many anti-inflammatory effects appear melanocortin-independent684

PT-141

Melanocortin receptors, with highest functional relevance at MC4R and MC3R; also binds MC1R and MC5R3242

Organism or Origin

KPV

Endogenous tripeptide corresponding to positions 11–13 of human α-MSH8490

PT-141

Synthetic analog of human α-MSH derived from POMC428190

Gene

KPV

POMC

PT-141

POMC

Summary

KPV and PT-141 sit closest together within the Melanocortin family, which gives them a broadly related biological identity. Their typical research and application settings separate fairly clearly: KPV is more often discussed in the realm of Immunology and inflammation, Gastroenterology, and Dermatology and aesthetics, whereas PT-141 is more often associated with the realm of Reproductive health. Both appear to work through Signaling modulator, but the functional emphasis still separates, with KPV leaning toward Anti-inflammatory and Immune regulation and PT-141 leaning toward . KPV has a more natural endogenous origin, while PT-141 is closer to synthetic analog background and their development context also differs, with KPV in Preclinical development while PT-141 is approved. KPV takes the form of a linear peptide, whereas PT-141 is closer to a cyclic peptide, while PT-141 incorporates acetylation features that are not part of KPV.

Related articles

No related articles are linked to these peptides yet.

Sources

6Keratinocyte And Dermal..., https://oathresearch.com/2026/03/27/kpv-tripeptide-nfkb-inhibition-anti-inflammatory-mechanisms-cell-culture/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/
32PT-141 (Bremelanotide): Research Applications and Quality ..., https://wheretofindpeptides.com/research/pt-141-bremelanotide-research-applications-and-quality-assessment-1
42[PDF] The Discovery and Development of Bremelanotide (PT-141), https://www.benchchem.com/pdf/The_Discovery_and_Development_of_Bremelanotide_PT_141_A_Technical_Guide.pdf
81Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC2253185/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/
101PT-141 (Bremelanotide Acetate): Clinical Overview, Uses ... - eNavvi, https://enavvi.com/insights/pt-141-bremelanotide-for-sexual-dysfunction-clinical-guide-for-physicians